Ellagic acid inhibits migration and invasion by prostate cancer cell lines

Asian Pac J Cancer Prev. 2013;14(5):2859-63. doi: 10.7314/apjcp.2013.14.5.2859.

Abstract

Polyphenolic compounds from pomegranate fruit extracts (PFEs) have been reported to possess antiproliferative, pro-apoptotic, anti-inflammatory and anti-invasion effects in prostate and other cancers. However, the mechanisms responsible for the inhibition of cancer invasion remain to be clarified. In the present study, we investigated anti-invasive effects of ellagic acid (EA) in androgen-independent human (PC-3) and rat (PLS10) prostate cancer cell lines in vitro. The results indicated that non-toxic concentrations of EA significantly inhibited the motility and invasion of cells examined in migration and invasion assays. The EA treatment slightly decreased secretion of matrix metalloproteinase (MMP)-2 but not MMP-9 from both cell lines. We further found that EA significantly reduced proteolytic activity of collagenase/gelatinase secreted from the PLS-10 cell line. Collagenase IV activity was also concentration-dependently inhibited by EA. These results demonstrated that EA has an ability to inhibit invasive potential of prostate cancer cells through action on protease activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Cell Proliferation / drug effects
  • Collagenases / metabolism*
  • Ellagic Acid / pharmacology*
  • Gelatinases / metabolism*
  • Humans
  • Lythraceae
  • Male
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Neoplasm Invasiveness / pathology*
  • Plant Extracts / pharmacology
  • Prostatic Neoplasms
  • Rats
  • Rats, Inbred F344

Substances

  • Plant Extracts
  • Ellagic Acid
  • Collagenases
  • Gelatinases
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • Mmp2 protein, rat
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • Mmp9 protein, rat